Curtis’s connection to lupus is deeply personal—rooted in a commitment to honoring his late daughter, Rashara. After her passing, Curtis and his family transformed their grief into purpose, raising ...

For patients who have spent years managing unpredictable and debilitating autoimmune conditions like lupus, the findings ...

More than three-quarters of lupus patients taking obinutuzumab (Gazvya) had a significant improvement in their symptoms after a year on the drug, researchers reported March 6 in The New England ...

Lupus is more common in Black people, and symptoms can be different too. Here's what to look out for and how to treat it.

The walk will take place Saturday, March 21 at Tyrrell Park, bringing together survivors, families and supporters to ...

Hello, health and wellness readers. My name is Kaitlin, your guide to the latest health news you may have missed. Researchers believe they may have found the root cause of lupus, a chronic condition ...

Cutaneous lupus erythematosus is a chronic autoimmune disease with few treatment options and no approved targeted therapies.

The FDA has granted fast track designation to the anti-FcRn agent nipocalimab for the treatment of adults with systemic lupus ...

Phase 3 trial data show that obinutuzumab significantly reduces disease activity in very active extrarenal lupus.

Scientists may have pinpointed a primary cause of lupus, a chronic autoimmune disease. Researchers from Northwestern Medicine in Chicago and Brigham and Women’s Hospital in Boston claim they have ...

Clinicians must balance maintaining lupus nephritis remission against the cumulative harms of long-term immunosuppressive therapy.